SCM
TARA icon

Sio Capital Management’s Protara Therapeutics TARA Stock Holding History

Sio Capital Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.34M Sell
1,921,872
-47,967
-2% -$228K 1.21% 29
2026
Q1 		$10.3M Buy
1,969,839
+254,445
+15% +$1.51M 1.47% 24
2025
Q4 		$9.14M Buy
+1,715,394
New +$9.54M 1.44% 22
2025
Q2 		– Sell
-1,514,300
Closed -$6.45M – 61
2025
Q1 		$6.45M Buy
1,514,300
+76,800
+5% +$343K 1.92% 15
2024
Q4 		$7.59M Buy
+1,437,500
New +$4.64M 2.14% 18

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Sio Capital Management's TARA Position: Q2 2026 in Review

Sio Capital Management reduced its Protara Therapeutics (TARA) stake by 2.4% in Q2 2026, selling an estimated $228K and leaving 1,921,872 shares worth $7.34M. The position accounts for 1.21% of the portfolio, ranked #29.

Sio Capital Management first reported a position in TARA in Q4 2024 and has held it in 5 quarters since. The position peaked at $10.3M in Q1 2026. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Sio Capital Management held 1,921,872 shares of Protara Therapeutics worth $7.34M as of Q2 2026.
  • Sio Capital Management sold 47,967 Protara Therapeutics shares in Q2 2026, an estimated $228K.
  • Protara Therapeutics made up 1.21% of Sio Capital Management's portfolio in Q2 2026, its #29 holding.
  • Sio Capital Management first reported a position in Protara Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Sio Capital Management's Protara Therapeutics position peaked at $10.3M in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.